POEMS syndrome: 2014 Update on diagnosis, risk-stratification, and management

American Journal of Hematology

Volumn 89, Issue 2, 2014, Pages 213-223

  Dispenzieri, Angela ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CORTICOSTEROID; LENALIDOMIDE; MOLECULAR MARKER; THALIDOMIDE;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BONE MARROW BIOPSY; CANCER RADIOTHERAPY; CANCER THERAPY; DISEASE ASSOCIATION; ENDOCRINE DISEASE; HUMAN; PAPILLEDEMA; PATHOGENESIS; PERIPHERAL NEUROPATHY; PLASMACYTOMA; POEMS SYNDROME; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; SYSTEMIC THERAPY; THROMBOCYTOSIS; TREATMENT RESPONSE; BONE MARROW; DIFFERENTIAL DIAGNOSIS; PATHOLOGY; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

BONE MARROW; DIAGNOSIS, DIFFERENTIAL; GIANT LYMPH NODE HYPERPLASIA; HUMANS; POEMS SYNDROME; RISK FACTORS; TREATMENT OUTCOME;

EID: 84893907858     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23644     Document Type: Article

References (179)

1. Bardwick PA, Zvaifler NJ, Gill GN, et al. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine 1980;59:311-322.
2. Takatsuki K, Sanada I. Plasma cell dyscrasia with polyneuropathy and endocrine disorder: Clinical and laboratory features of 109 reported cases. Jpn J Clin Oncol 1983;13:543-555.
3. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: A study of 102 cases in Japan. Neurology 1984;34:712-720.
4. Singh D, Wadhwa J, Kumar L, et al. POEMS syndrome: Experience with fourteen cases. Leuk Lymphoma 2003;44:1749-1752.
5. Soubrier MJ, Dubost JJ, Sauvezie BJ. POEMS syndrome: A study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. Am J Med 1994;97:543-553.
6. Zhang B, Song X, Liang B, et al. The clinical study of POEMS syndrome in China. Neuro Endocrinol Lett 2010;31:229-237.
7. Li J, Zhou DB, Huang Z, et al. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol 2011;90:819-826.
8. Kulkarni GB, Mahadevan A, Taly AB, et al. Clinicopathological profile of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome. J Clin Neurosci 2011;18:356-360.
9. Nasu S, Misawa S, Sekiguchi Y, et al. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2012;83:476-479.
10. Dispenzieri A. POEMS Syndrome. Blood Rev 2007;21:285-299.
11. Watanabe O, Arimura K, Kitajima I, et al. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome [letter]. Lancet 1996;347:702.
12. Soubrier M, Guillon R, Dubost JJ, et al. Arterial obliteration in POEMS syndrome: Possible role of vascular endothelial growth factor. J Rheumatol 1998;25:813-815.
13. Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve 1998;21:1390-1397.
14. Nishi J, Arimura K, Utsunomiya A, et al. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease. Br J Haematol 1999;104:482-485.
15. Soubrier M, Sauron C, Souweine B, et al. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kidney Dis 1999;34:633-638.
16. Niimi H, Arimura K, Jonosono M, et al. VEGF is causative for pulmonary hypertension in a patient with Crow- Fukase (POEMS) syndrome. Intern Med 2000;39:1101-1104.
17. Scarlato M, Previtali SC, Carpo M, et al. Polyneuropathy in POEMS syndrome: Role of angiogenic factors in the pathogenesis. Brain 2005;128:1911-1920.
18. Kuwabara S, Misawa S, Kanai K, et al. Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology 2006;66:105-107.
19. Mineta M, Hatori M, Sano H, et al. Recurrent Crow-Fukase syndrome associated with increased serum levels of vascular endothelial growth factor: A case report and review of the literature. Tohoku J Exp Med 2006;210:269-277.
20. D'Souza A, Hayman SR, Buadi F, et al. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood 2011;118:4663-4665.
21. Kanai K, Kuwabara S, Misawa S, et al. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome. Intern Med 2007;46:311-313.
22. Straume O, Bergheim J, Ernst P. Bevacizumab therapy for POEMS syndrome. Blood 2006;107:4972-4973; author reply 4973-4974.
23. Dietrich PY, Duchosal MA. Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome. Ann Oncol 2008;19:595.
24. Badros A, Porter N, Zimrin A. Bevacizumab therapy for POEMS syndrome. Blood 2005;106:1135.
25. Ohwada C, Nakaseko C, Sakai S, et al. Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome. Bone Marrow Transplant 2009;43:739-740.
26. Badros A. Bevacizumab therapy for POEMS syndrome. Blood 2006;107:author reply 4973-4974.
27. Samaras P, Bauer S, Stenner-Liewen F, et al. Treatment of POEMS syndrome with bevacizumab. Haematologica 2007;92:1438-1439.
28. Sekiguchi Y, Misawa S, Shibuya K, et al. Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome. J Neurol Neurosurgery Psychiatry, 2013;84(12):1346-1348.
29. Soubrier M, Dubost JJ, Serre AF, et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum 1997;40:786-787.
30. Endo I, Mitsui T, Nishino M, et al. Diurnal fluctuation of edema synchronized with plasma VEGF concentration in a patient with POEMS syndrome. Int Med 2002;41:1196-1198.
31. Nakano A, Mitsui T, Endo I, et al. Solitary plasmacytoma with VEGF overproduction: Report of a patient with polyneuropathy. Neurology 2001;56:818-819.
32. Koga H, Tokunaga Y, Hisamoto T, et al. Ratio of serum vascular endothelial growth factor to platelet count correlates with disease activity in a patient with POEMS syndrome. Eur J Intern Med 2002;13:70-74.
33. Kanai K, Sawai S, Sogawa K, et al. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome. Neurology 2012;79:575-582.
34. Soubrier M, Labauge P, Jouanel P, et al. Restricted use of Vlambda genes in POEMS syndrome. Haematologica 2004;89:ECR02.
35. Nakaseko C, Abe D, Takeuchi M, et al. Restricted oligo-clonal usage of monoclonal immunoglobulin {lambda} light chain germline in POEMS syndrome. ASH Annu Meet Abstr 2007;110:2483.
36. Aravamudan B, Tong C, Lacy MQ, et al. Immunoglobulin variable light chain restriction, cytokine expression and plasma cell-stromal cell interactions in POEMS syndrome patients. ASH Annu Meet Abstr 2008;112:2744.
37. Kang WY, Shen KN, Duan MH, et al. 14q32 translocations and 13q14 deletions are common cytogenetic abnormalities in POEMS syndrome. Eur J Haematol, 2013;91(6):490-496. Prepublished on 2013/08/21 as DOI 10.1111/ejh.12189.
38. Bryce AH, Ketterling RP, Gertz MA, et al. A novel report of cig-FISH and cytogenetics in POEMS syndrome. Am J Hematol 2008;83:840-841.
39. Alberti MA, Martinez-Yelamos S, Fernandez A, et al. 18F-FDG PET/CT in the evaluation of POEMS syndrome. Eur J Radiol 2010;76:180-182.
40. Nobile-Orazio E, Terenghi F, Giannotta C, et al. Serum VEGF levels in POEMS syndrome and in immune-mediated neuropathies. Neurology 2009;72:1024-1026.
41. Briani C, Fabrizi GM, Ruggero S, et al. Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias. Muscle Nerve 2010;43:164-167.
42. Dao LN, Hanson CA, Dispenzieri A, et al. Bone marrow histopathology in POEMS syndrome: A distinctive combination of plasma cell, lymphoid and myeloid findings in 87 patients. Blood 2011;117:6438-6444.
43. Dispenzieri A. Castleman disease. Cancer Treat Res 2008;142:293-330.
44. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: Definitions and long-term outcome. Blood 2003;101:2496-2506.
45. Kelly JJ Jr, Kyle RA, Miles JM, et al. Osteosclerotic myeloma and peripheral neuropathy. Neurology 1983;33:202-210.
46. Koike H, Iijima M, Mori K, et al. Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome. J Neurol Neurosurgery Psychiatry 2008;79:1171-1179.
47. Kaushik M, Pulido JS, Abreu R, et al. Ocular findings in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome. Ophthalmology 2011;118:778-782.
48. Barete S, Mouawad R, Choquet S, et al. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: Impact of autologous hematopoietic stem cell transplantation. Arch Dermatol 2010;146:615-623.
49. Bachmeyer C. Acquired facial atrophy: A neglected clinical sign of POEMS syndrome. Am J Hematol 2012;87:131.
50. Lee FY, Chiu HC. POEMS syndrome with calciphylaxis: A case report. Acta Derm Venereol 2011;91:96-97.
51. De Roma I, Filotico R, Cea M, et al. Calciphylaxis in a patient with POEMS syndrome without renal failure and/or hyperparathyroidism. A case report. Ann Ital Med Int 2004;19:283-287.
52. Allam JS, Kennedy CC, Aksamit TR, et al. Pulmonary manifestations in patients with POEMS syndrome: A retrospective review of 137 patients. Chest 2008;133:969-974.
53. Lesprit P, Authier FJ, Gherardi R, et al. Acute arterial obliteration: A new feature of the POEMS syndrome? Medicine 1996;75:226-232.
54. Dupont SA, Dispenzieri A, Mauermann ML, et al. Cerebral infarction in POEMS syndrome: Incidence, risk factors, and imaging characteristics. Neurology 2009;73:1308-1312.
55. Saida K, Kawakami H, Ohta M, et al. Coagulation and vascular abnormalities in Crow-Fukase syndrome. Muscle Nerve 1997;20:486-492.
56. Hashiguchi T, Arimura K, Matsumuro K, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve 2000;23:1051-1056.
57. Loeb JM, Hauger PH, Carney JD, et al. Refractory ascites due to POEMS syndrome. Gastroenterology 1989;96:247-249.
58. Tokashiki T, Hashiguchi T, Arimura K, et al. Predictive value of serial platelet count and VEGF determination for the management of DIC in the Crow-Fukase (POEMS) syndrome. Intern Med 2003;42:1240-1243.
59. Cui RT, Yu SY, Huang XS, et al. The characteristics of ascites in patients with POEMS syndrome. Annals of hematology, 2013. Prepublished on 2013/07/03 as DOI 10.1007/s00277-013-1829-7.
60. Kelly JJ Jr. The electrodiagnostic findings in peripheral neuropathy associated with monoclonal gammopathy. Muscle Nerve 1983;6:504-509.
61. Sung JY, Kuwabara S, Ogawara K, et al. Patterns of nerve conduction abnormalities in POEMS syndrome. Muscle Nerve 2002;26:189-193.
62. Min JH, Hong YH, Lee KW. Electrophysiological features of patients with POEMS syndrome. Clin Neurophysiol 2005;116:965-968.
63. Mauermann ML, Sorenson EJ, Dispenzieri A, et al. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP. J Neurol Neurosurgery Psychiatry 2012;83:480-486.
64. Vital C, Vital A, Ferrer X, et al. Crow-Fukase (POEMS) syndrome: a study of peripheral nerve biopsy in five new cases. J Peripher Nerv Syst 2003;8:136-144.
65. Orefice G, Morra VB, De Michele G, et al. POEMS syndrome: Clinical, pathological and immunological study of a case. Neurol Res 1994;16:477-480.
66. Crisci C, Barbieri F, Parente D, et al. POEMS syndrome: Follow-up study of a case. Clin Neurol Neurosurgery 1992;94:65-68.
67. Bergouignan FX, Massonnat R, Vital C, et al. Uncompacted lamellae in three patients with POEMS syndrome. Eur Neurol 1987;27:173-181.
68. Khuda SE, Loo WM, Janz S, et al. Deregulation of c-Myc Confers distinct survival requirements for memory B cells, plasma cells, and their progenitors. J Immunol 2008;181:7537-7549.
69. Arimura K. [Increased vascular endothelial growth factor (VEGF) is causative in Crow-Fukase syndrome]. [Japanese]. Rinsho Shinkeigaku Clin Neurol 1999;39:84-85.
70. Ghandi GY, Basu R, Dispenzieri A, et al. Endocrinopathy in POEMS syndrome: The Mayo clinic experience. Mayo Clin Proc 2007;82:836-842.
71. Tanaka O, Ohsawa T. The POEMS syndrome: Report of three cases with radiographic abnormalities. Radiologe 1984;24:472-474.
72. Chong ST, Beasley HS, Daffner RH. POEMS syndrome: Radiographic appearance with MRI correlation. Skeletal Radiol 2006;35:690-695.
73. Lesprit P, Godeau B, Authier FJ, et al. Pulmonary hypertension in POEMS syndrome: A new feature mediated by cytokines. Am J Respir Crit Care Med 1998;157:907-911.
74. Ishikawa O, Nihei Y, Ishikawa H. The skin changes of POEMS syndrome. Br J Dermatol 1987;117:523-526.
75. Jitsukawa K, Hayashi Y, Sato S, et al. Cutaneous angioma in Crow-Fukase syndrome: The nature of globules within the endothelial cells. J Dermatol 1988;15:513-522.
76. Rongioletti F, Gambini C, Lerza R. Glomeruloid hemangioma. A cutaneous marker of POEMS syndrome. Am J Dermatopathol 1994;16:175-178.
77. Santoro L, Manganelli F, Bruno R, et al. Sural nerve and epidermal vascular abnormalities in a case of POEMS syndrome. Eur J Neurol 2006;13:99-102.
78. Stankowski-Drengler T, Gertz MA, Katzmann JA, et al. Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome. Am J Hematol 2010;85:431-434.
79. Sanada S, Ookawara S, Karube H, et al. Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation. Am J Kidney Dis 2006;47:672-679.
80. Navis GJ, Dullaart RP, Vellenga E, et al. Renal disease in POEMS syndrome: Report on a case and review of the literature. [Review] [25 refs]. Nephrol Dial Transplant 1994;9:1477-1481.
81. Viard JP, Lesavre P, Boitard C, et al. POEMS syndrome presenting as systemic sclerosis. Clinical and pathologic study of a case with microangiopathic glomerular lesions. Am J Med 1988;84:524-528.
82. Sano M, Terasaki T, Koyama A, et al. Glomerular lesions associated with the Crow-Fukase syndrome. Virchows Archiv A Pathol Anat Histopathol 1986;409:3-9.
83. Takazoe K, Shimada T, Kawamura T, et al. Possible mechanism of progressive renal failure in Crow-Fukase syndrome [letter]. Clin Nephrol 1997;47:66-67.
84. Mizuiri S, Mitsuo K, Sakai K, et al. Renal involvement in POEMS syndrome. Nephron 1991;59:153-156.
85. Stewart PM, McIntyre MA, Edwards CR. The endocrinopathy of POEMS syndrome. Scott Med J 1989;34:520-522.
86. Nakamoto Y, Imai H, Yasuda T, et al. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transplant 1999;14:2370-2378.
87. Fukatsu A, Ito Y, Yuzawa Y, et al. A case of POEMS syndrome showing elevated serum interleukin 6 and abnormal expression of interleukin 6 in the kidney. Nephron 1992;62:47-51.
88. Dispenzieri A, Moreno-Aspitia A, Lacy MQ, et al. Peripheral blood stem cell transplant (PBSCT) in a large series of patients with POEMS syndrome. Biol Blood Marrow Tr 2004;10:14-15.
89. Shirabe S, Kishikawa M, Mine M, et al. Crow-Fukase syndrome associated with extramedullary plasmacytoma. [Review] [11 refs]. Jpn J Med 1991;30:64-66.
90. Thajeb P, Chee CY, Lo SF, et al. The POEMS syndrome among Chinese: Association with Castleman's disease and some immunological abnormalities. Acta Neurol Scand 1989;80:492-500.
91. Papo T, Soubrier M, Marcelin AG, et al. Human herpesvirus 8 infection, Castleman's disease and POEMS syndrome [letter]. Br J Haematol 1999;104:932-933.
92. Vital C, Gherardi R, Vital A, et al. Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes syndrome. Ultrastructural study of peripheral nerve biopsy from 22 patients. Acta Neuropathol 1994;87:302-307.
93. Yang SG, Cho KH, Bang YJ, et al. A case of glomeruloid hemangioma associated with multicentric Castleman's disease. Am J Dermatopathol 1998;20:266-270.
94. Kobayashi H, Ii K, Sano T, et al. Plasma-cell dyscrasia with polyneuropathy and endocrine disorders associated with dysfunction of salivary glands. Am J Surg Pathol 1985;9:759-763.
95. Bitter M, Komaiko W, Franklin W. Giant lymph node hyperplasia with osteoblastic bone lesions and the POEMS (Takatsuki's) syndrome. Cancer 1985;56:188-194.
96. Lapresle J, Lacroix-Ciaudo C, Reynes M, et al. [Crow-Fukase syndrome (POEMS syndrome) and osseous mastocytosis secondary to Castleman's angiofollicular lymphoid hyperplasia]. [French]. Rev Neurol 1986;142:731-737.
97. Gherardi R, Baudrimont M, Kujas M, et al. Pathological findings in three non-Japanese patients with the POEMS syndrome. Virchows Arch A Pathol Anat Histopathol 1988;413:357-365.
98. Dworak O, Tschubel K, Zhou H, et al. [Angiofollicular lymphatic hyperplasia with plasmacytoma and polyneuropathy: A case report with immunohistochemical study]. [German]. Klin Wochenschr 1988;66:591-595.
99. Rolon PG, Audouin J, Diebold J, et al. Multicentric angiofollicular lymph node hyperplasia associated with a solitary osteolytic costal IgG lambda myeloma. POEMS syndrome in a South American (Paraguayan) patient. Pathol Res Pract 1989;185:468-475.
100. Carcaterra A, Santini R, Sozzi G, et al. [Crow-Fukase syndrome (POEMS syndrome). The first Italian presentation of a case and review of the literature]. [Review] [33 refs] [Italian]. G Ital Dermatol Venereol 1990;125:97-103.
101. Chan JK, Fletcher CD, Hicklin GA, et al. Glomeruloid hemangioma. A distinctive cutaneous lesion of multicentric Castleman's disease associated with POEMS syndrome. Am J Surg Pathol 1990;14:1036-1046.
102. Brazis PW, Liesegang TJ, Bolling JP, et al. When do optic disc edema and peripheral neuropathy constitute poetry? Surv Ophthalmol 1990;35:219-225.
103. Munoz G, Geijo P, Moldenhauer F, et al. Plasmacellular Castleman's disease and POEMS syndrome. Histopathology 1990;17:172-174.
104. Gherardi RK, Malapert D, Degos JD. Castleman disease-POEMS syndrome overlap [letter; comment]. Ann Int Med 1991;114:520-521.
105. Myers BM, Miralles GD, Taylor CA, et al. POEMS syndrome with idiopathic flushing mimicking carcinoid syndrome. Am J Med 1991;90:646-648.
106. Coto V, Auletta M, Oliviero U, et al. POEMS syndrome: An Italian case with diagnostic and therapeutic implications. Ann Ital Med Int 1991;6:416-419.
107. Bosco J, Pathmanathan R. POEMS syndrome, osteosclerotic myeloma and Castleman's disease: A case report. Aust N Z J Med 1991;21:454-456.
108. Mandler RN, Kerrigan DP, Smart J, et al. Castleman's disease in POEMS syndrome with elevated interleukin-6 [see comments]. Cancer 1992;69:2697-2703.
109. Nakazawa K, Itoh N, Shigematsu H, et al. An autopsy case of Crow-Fukase (POEMS) syndrome with a high level of IL-6 in the ascites. Special reference to glomerular lesions. Acta Pathol Jpn 1992;42:651-656.
110. Emile C, Danon F, Fermand JP, et al. Castleman disease in POEMS syndrome with elevated interleukin-6 [letter; comment]. Cancer 1993;71:874.
111. Judge MR, McGibbon DH, Thompson RP. Angioendotheliomatosis associated with Castleman's lymphoma and POEMS syndrome. Clin Exp Dermatol 1993;18:360-362.
112. Del Rio R, Alsina M, Monteagudo J, et al. POEMS syndrome and multiple angioproliferative lesions mimicking generalized histiocytomas. Acta Dermato Venereologica 1994;74:388-390.
113. Bhatia M, Maheshwari MC. Angiofollicular lymphoid hyperplasia presenting as POEMS syndrome. J Assoc Physicians India 1994;42:751-752.
114. Adelman HM, Cacciatore ML, Pascual JF, et al. Case report: Castleman disease in association with POEMS. Am J Med Sci 1994;307:112-114.
115. Pareyson D, Marazzi R, Confalonieri P, et al. The POEMS syndrome: Report of six cases. Ital J Neurol Sci 1994;15:353-358.
116. Ku A, Lachmann E, Tunkel R, et al. Severe polyneuropathy: Initial manifestation of Castleman's disease associated with POEMS syndrome. Arch Phys Med Rehabil 1995;76:692-694.
117. Huang CC, Chu CC. Poor response to intravenous immunoglobulin therapy in patients with Castleman's disease and the POEMS syndrome [letter; comment]. J Neurol 1996;243:726-727.
118. Chang YJ, Huang CC, Chu CC. Intravenous immunoglobulin therapy in POEMS syndrome: A case report. Zhonghua Yi Xue Za Zhi (Taipei) 1996;58:366-369.
119. Forster A, Muri R. [Recurrent cerebrovascular insult--manifestation of POEMS syndrome?]. [German]. Schweiz Med Wochenschr 1998;128:1059-1064.
120. Belec L, Mohamed AS, Authier FJ, et al. Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease. Blood 1999;93:3643-3653.
121. Belec L, Authier FJ, Mohamed AS, et al. Antibodies to human herpesvirus 8 in POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes) syndrome with multicentric Castleman's disease. Clin Infect Dis 1999;28:678-679.
122. Gaba AR, Stein RS, Sweet DL, et al. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978;69:86-90.
123. Hineman VL, Phyliky RL, Banks PM. Angiofollicular lymph node hyperplasia and peripheral neuropathy: Association with monoclonal gammopathy. Mayo Clin Proc 1982;57:379-382.
124. Black DA, Forgacs I, Davies DR, et al. Pseudotumour cerebri in a patient with Castleman's disease. Postgrad Med J 1988;64:217-219.
125. Feigert JM, Sweet DL, Coleman M, et al. Multicentric angiofollicular lymph node hyperplasia with peripheral neuropathy, pseudotumor cerebri, IgA dysproteinemia, and thrombocytosis in women. A distinct syndrome [see comments]. Ann Intern Med 1990;113:362-367.
126. Menke DM, Tiemann M, Camoriano JK, et al. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Am J Clin Pathol 1996;105:268-276.
127. Mallory A, Spink WW. Angiomatous lymphoid hamartoma in the retroperitoneum presenting with neurologic signs in the legs. Ann Intern Med 1968;69:305-308.
128. Anonymous. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-1987. A 59-year-old woman with progressive polyneuropathy and monoclonal gammopathy. N Engl J Med 1987;316:606-618.
129. Yu GS, Carson JW. Giant lymph-node hyperplasia, plasma-cell type, of the mediastinum, with peripheral neuropathy. Am J Clin Pathol 1976;66:46-53.
130. Weisenburger DD, Nathwani BN, Winberg CD, et al. Multicentric angiofollicular lymph node hyperplasia: A clinicopathologic study of 16 cases. Hum Pathol 1985;16:162-172.
131. Hineman VL, Phyliky RL, Banks PM. Angiofollicular lymph node hyperplasia and peripheral neuropathy: Association with monoclonal gammopathy. Mayo Clin Proc 1982;57:379-382.
132. Donaghy M, Hall P, Gawler J, et al. Peripheral neuropathy associated with Castleman's disease. J Neurol Sci 1989;89:253-267.
133. Ganti AK, Pipinos I, Culcea E, et al. Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome. Am J Hematol 2005;79:206-210.
134. Menke DM, Camoriano JK, Banks PM. Angiofollicular lymph node hyperplasia: A comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol 1992;5:525-530.
135. Donaghy M, Hall P, Gawler J, et al. Peripheral neuropathy associated with Castleman's disease. J Neurol Sci 1989;89:253-267.
136. Li J, Zhang W, Jiao L, et al. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood 2011;117:6445-6449.
137. Giglia F, Chiapparini L, Fariselli L, et al. POEMS syndrome: Relapse after successful autologous peripheral blood stem cell transplantation. Neuromuscul Disord 2007;17:980-982.
138. Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 2004;104:3400-3407.
139. Schliamser LM, Hardan I, Sharif D, et al. Significant improvement of POEMS syndrome with pulmonary hypertension following autologous peripheral blood stem cell transplant. Blood 2003;102:5664 abstract.
140. Soubrier M, Ruivard M, Dubost JJ, et al. Successful use of autologous bone marrow transplantation in treating a patient with POEMS syndrome. Bone Marrow Transplant 2002;30:61-62.
141. Peggs KS, Paneesha S, Kottaridis PD, et al. Peripheral blood stem cell transplantation for POEMS syndrome. Bone Marrow Transplant 2002;30:401-404.
142. Jaccard A, Royer B, Bordessoule D, et al. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood 2002;99:3057-3059.
143. Rovira M, Carreras E, Blade J, et al. Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation. Br J Haematol 2001;115:373-375.
144. Hogan WJ, Lacy MQ, Wiseman GA, et al. Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation. Bone Marrow Transplant 2001;28:305-309.
145. Dispenzieri A, Lacy MQ, Hayman SR, et al. Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol 2008;80:397-406.
146. Kuwabara S, Misawa S, Kanai K, et al. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome. Neurology 2008;71:1691-1695.
147. Laurenti L, De Matteis S, Sabatelli M, et al. Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome. Leuk Res 2008;32:1309-1312.
148. Kojima H, Katsuoka Y, Katsura Y, et al. Successful treatment of a patient with POEMS syndrome by tandem high-dose chemotherapy with autologous CD34+ purged stem cell rescue. Int J Hematol 2006;84:182-185.
149. Imai N, Taguchi J, Yagi N, et al. Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantation. Neuromuscul Disord 2009;19:363-365.
150. D'Souza A, Lacy M, Gertz M, et al. Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): A single-center experience. Blood 2012;120:56-62.
151. Dispenzieri A, Klein CJ, Mauermann ML. Lenalidomide therapy in a patient with POEMS syndrome. Blood 2007;110:1075-1076.
152. Jaccard A, Abraham J, Recher C, et al. Lenalidomide Therapy in Nine Patients with POEMS Syndrome. ASH Annu Meet Abstr 2009;114:3872.
153. Tang X, Shi X, Sun A, et al. Successful bortezomib-based treatment in POEMS syndrome. Eur J Haematol 2009;83:609-610.
154. Kaygusuz I, Tezcan H, Cetiner M, et al. Bortezomib: a new therapeutic option for POEMS syndrome. Eur J Haematol 2010;84:175-177.
155. Buxhofer-Ausch V, Gisslinger B, Stangl G, et al. Successful treatment sequence incorporating bevacizumab for therapy of polyneuropathy in two patients with POEMS syndrome. Leuk Res 2012;36:e98-e100.
156. Terracciano C, Fiore S, Doldo E, et al. Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin. Muscle Nerve 2010;42:445-448.
157. Goto H, Nishio M, Kumano K, et al. Discrepancy between disease activity and levels of vascular endothelial growth factor in a patient with POEMS syndrome successfully treated with autologous stem-cell transplantation. Bone Marrow Transplant 2008;42:627-629.
158. Sethi S, Theis JD, Leung N, et al. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin J Am Soc Nephrol 2010;5:2180-2187.
159. Dispenzieri A. Ushering in a new era for POEMS. Blood 2011;117:6405-6406.
160. Morley JB, Schwieger AC. The relation between chronic polyneuropathy and osteosclerotic myeloma. J Neurol Neurosurgery Psychiatry 1967;30:432-442.
161. Davis L, Drachman D. Myeloma Neuropathy. Arch Neurol 1972;27:507-511.
162. Iwashita H, Ohnishi A, Asada M, et al. Polyneuropathy, skin hyperpigmentation, edema, and hypertrichosis in localized osteosclerotic myeloma. Neurology 1977;27:675-681.
163. Reitan JB, Pape E, Fossa SD, et al. Osteosclerotic myeloma with polyneuropathy. Acta Med Scand 1980;208:137-144.
164. Humeniuk MS, Gertz MA, Lacy MQ, et al. Outcomes of patients with POEMS syndrome treated initially with radiation. Blood, 2013;122(1):66-73. 10.1182/blood-2013-03-487025.
165. Arima F, Dohmen K, Yamano Y, et al. [Five cases of Crow-Fukase syndrome]. [Japanese]. Fukuoka Igaku Zasshi Fukuoka Acta Medica 1992;83:112-120.
166. Wong VA, Wade NK. POEMS syndrome: An unusual cause of bilateral optic disk swelling. Am J Ophthalmol 1998;126:452-454.
167. Wiesmann A, Weissert R, Kanz L, et al. Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation. Blood 2002;100:2679-2680.
168. Dispenzieri A, Kyle RA, Lacy MQ, et al. Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: A case-control study. Blood 2004;103:3960-3963.
169. Takai K, Niikuni K, Kurasaki T. [Successful treatment of POEMS syndrome with high-dose chemotherapy and autologous peripheral blood stem cell transplantation]. Rinsho Ketsueki 2004;45:1111-1114.
170. Kastritis E, Terpos E, Anagnostopoulos A, et al. Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support. Clin Lymphoma Myeloma 2006;7:73-76.
171. Imai N, Kitamura E, Tachibana T, et al. Efficacy of autologous peripheral blood stem cell transplantation in POEMS syndrome with polyneuropathy. Intern Med 2007;46:135-138.
172. Sinisalo M, Hietaharju A, Sauranen J, et al. Thalidomide in POEMS syndrome: Case report. Am J Hematol 2004;76:66-68.
173. Kim SY, Lee SA, Ryoo HM, et al. Thalidomide for POEMS syndrome. Ann Hematol 2006;85:545-546.
174. Kuwabara S, Misawa S, Kanai K, et al. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome. J Neurol Neurosurgery Psychiatry 2008;79:1255-1257.
175. Royer B, Merlusca L, Abraham J, et al. Efficacy of lenalidomide in POEMS syndrome: A retrospective study of 20 patients. Am J Hematol 2013;88:207-212.
176. Zeng K, Yang JR, Li J, et al. Effective induction therapy with subcutaneous administration of bortezomib for newly diagnosed POEMS syndrome: A case report and a review of the literature. Acta Haematol 2013;129:101-105.
177. Warsame R, Kohut IE, Dispenzieri A. Successful use of cyclophosphamide, bortezomib, and dexamethasone to treat a case of relapsed POEMS. Eur J Haematol 2012;88:549-550.
178. Ohguchi H, Ohba R, Onishi Y, et al. Successful treatment with bortezomib and thalidomide for POEMS syndrome. Ann Hematol 2011;90:1113-1114.
179. Dispenzieri A. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 2011;86:591-601.